Your browser doesn't support javascript.
loading
A miR-20a/MAPK1/c-Myc regulatory feedback loop regulates breast carcinogenesis and chemoresistance.
Si, Wengong; Shen, Jiaying; Du, Chengyong; Chen, Danni; Gu, Xidong; Li, Chenggong; Yao, Minya; Pan, Jie; Cheng, Junchi; Jiang, Donghai; Xu, Liang; Bao, Chang; Fu, Peifen; Fan, Weimin.
Affiliation
  • Si W; Program of Innovative Cancer Therapeutics, Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province 310003, China.
  • Shen J; Program of Innovative Cancer Therapeutics, Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province 310003, China.
  • Du C; Breast Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province 310003, China.
  • Chen D; Program of Innovative Cancer Therapeutics, Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province 310003, China.
  • Gu X; Department of Breast Surgery, the First Affiliate Hospital of Zhejiang Chinese Medical University, Hangzhou 310014, China.
  • Li C; Program of Innovative Cancer Therapeutics, Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province 310003, China.
  • Yao M; Breast Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province 310003, China.
  • Pan J; Program of Innovative Cancer Therapeutics, Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province 310003, China.
  • Cheng J; Program of Innovative Cancer Therapeutics, Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province 310003, China.
  • Jiang D; Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province 310003, China.
  • Xu L; Program of Innovative Cancer Therapeutics, Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province 310003, China.
  • Bao C; Clinical Research Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province 310003, China.
  • Fu P; Program of Innovative Cancer Therapeutics, Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province 310003, China.
  • Fan W; Breast Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province 310003, China.
Cell Death Differ ; 25(2): 406-420, 2018 02.
Article in En | MEDLINE | ID: mdl-29125598

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Proto-Oncogene Proteins c-myc / Mitogen-Activated Protein Kinase 1 / MicroRNAs / Antineoplastic Agents Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Cell Death Differ Year: 2018 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Proto-Oncogene Proteins c-myc / Mitogen-Activated Protein Kinase 1 / MicroRNAs / Antineoplastic Agents Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Cell Death Differ Year: 2018 Document type: Article Affiliation country: Country of publication: